Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Oncol. Jun 10, 2011; 2(6): 237-244
Published online Jun 10, 2011. doi: 10.5306/wjco.v2.i6.237
Published online Jun 10, 2011. doi: 10.5306/wjco.v2.i6.237
Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responses
Susana Inoges, Ascension Lopez-Diaz de Cerio, Helena Villanueva, Fernando Pastor, Elena Soria, Maurizio Bendandi, Lab of Immunotherapy - Oncology Division, Center for Applied Medical Research, Avda Pio XII, 55, 31008 Pamplona (Navarra), Spain
Susana Inoges, Maurizio Bendandi, Immunotherapy Program, Cell Therapy Area, University of Navarra Hospital, Avda. Pio XII, 36, 31008 Pamplona (Navarra), Spain
Author contributions: Inoges S and Lopez-Diaz de Cerio A analyzed and interpreted the data; Villanueva H, Pastor F and Soria E collected the data; Bendandi M interpreted the data and wrote the paper.
Correspondence to: Professor Maurizio Bendandi, Immunotherapy Program, Cell Therapy Area, University of Navarra Hospital, Avda. Pio XII, 36, 31008 Pamplona (Navarra), Spain. mbendandi@unav.es
Telephone: +34-948-194700-1004 Fax: +34-948-194714
Received: January 15, 2011
Revised: March 8, 2011
Accepted: March 15, 2011
Published online: June 10, 2011
Revised: March 8, 2011
Accepted: March 15, 2011
Published online: June 10, 2011
Core Tip